David Oakes
Concepts (490)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Parkinson Disease | 31 | 1989 | 67 |
Why?
| Survival Analysis | 9 | 1991 | 205 |
Why?
| Huntington Disease | 12 | 1989 | 30 |
Why?
| Levodopa | 11 | 1994 | 28 |
Why?
| Antiparkinson Agents | 9 | 1997 | 23 |
Why?
| Selegiline | 7 | 1989 | 16 |
Why?
| Models, Statistical | 5 | 1995 | 114 |
Why?
| Myocardial Infarction | 14 | 1988 | 129 |
Why?
| Clinical Trials as Topic | 8 | 1988 | 251 |
Why?
| Double-Blind Method | 29 | 1988 | 274 |
Why?
| Middle Aged | 63 | 1981 | 1161 |
Why?
| Humans | 101 | 1981 | 1856 |
Why?
| Aged | 48 | 1981 | 988 |
Why?
| Male | 73 | 1981 | 1553 |
Why?
| Female | 70 | 1981 | 1643 |
Why?
| Antioxidants | 5 | 1997 | 84 |
Why?
| Randomized Controlled Trials as Topic | 6 | 1989 | 176 |
Why?
| Occupational Diseases | 7 | 1981 | 51 |
Why?
| Adult | 47 | 1981 | 1317 |
Why?
| Proportional Hazards Models | 7 | 1989 | 123 |
Why?
| Monoamine Oxidase Inhibitors | 4 | 1993 | 16 |
Why?
| Indans | 3 | 2006 | 12 |
Why?
| Financing, Organized | 1 | 2001 | 8 |
Why?
| Peer Review, Research | 1 | 2001 | 14 |
Why?
| Life Tables | 2 | 1998 | 33 |
Why?
| Vitamin E | 4 | 1989 | 38 |
Why?
| Epidemiologic Methods | 2 | 1982 | 46 |
Why?
| Neuropsychological Tests | 7 | 2006 | 113 |
Why?
| Societies, Medical | 1 | 2001 | 90 |
Why?
| Desipramine | 2 | 2009 | 20 |
Why?
| Placebo Effect | 1 | 1999 | 26 |
Why?
| Genetic Testing | 5 | 2005 | 49 |
Why?
| Lidocaine | 2 | 2009 | 49 |
Why?
| Uric Acid | 2 | 2008 | 25 |
Why?
| Biological Markers | 7 | 1992 | 262 |
Why?
| Nerve Tissue Proteins | 4 | 2001 | 128 |
Why?
| Tomography, Emission-Computed, Single-Photon | 5 | 2001 | 33 |
Why?
| Disease Progression | 11 | 2001 | 244 |
Why?
| Patient Participation | 1 | 2008 | 40 |
Why?
| Arteriovenous Shunt, Surgical | 1 | 1998 | 15 |
Why?
| Motor Activity | 1 | 2009 | 104 |
Why?
| Angioplasty, Balloon | 1 | 1998 | 35 |
Why?
| Renal Dialysis | 1 | 1998 | 56 |
Why?
| Condylomata Acuminata | 5 | 1988 | 16 |
Why?
| Multicenter Studies as Topic | 5 | 1989 | 70 |
Why?
| Tocopherols | 2 | 2002 | 9 |
Why?
| Follow-Up Studies | 15 | 1982 | 553 |
Why?
| Diltiazem | 5 | 1988 | 15 |
Why?
| Neurologic Examination | 6 | 1982 | 64 |
Why?
| Tetrabenazine | 2 | 2003 | 3 |
Why?
| Trinucleotide Repeats | 3 | 2006 | 15 |
Why?
| Communication | 1 | 2008 | 116 |
Why?
| Retrospective Studies | 9 | 1982 | 653 |
Why?
| Chi-Square Distribution | 6 | 2002 | 179 |
Why?
| Age of Onset | 3 | 2003 | 64 |
Why?
| Cocaine | 3 | 2001 | 33 |
Why?
| Picolinic Acids | 2 | 1993 | 5 |
Why?
| Neuroprotective Agents | 2 | 2004 | 60 |
Why?
| Psychoses, Substance-Induced | 2 | 2001 | 8 |
Why?
| Ubiquinone | 2 | 2002 | 11 |
Why?
| Mortality | 2 | 1983 | 50 |
Why?
| Apolipoprotein A-II | 1 | 1992 | 8 |
Why?
| Severity of Illness Index | 8 | 1993 | 358 |
Why?
| Anesthetics, Local | 2 | 2009 | 50 |
Why?
| Lipids | 4 | 1994 | 97 |
Why?
| Probability | 5 | 1986 | 190 |
Why?
| Longitudinal Studies | 7 | 1985 | 195 |
Why?
| Spleen | 3 | 1981 | 129 |
Why?
| Triglycerides | 1 | 1992 | 48 |
Why?
| Adrenergic Uptake Inhibitors | 2 | 2008 | 14 |
Why?
| Respiratory Tract Diseases | 2 | 1982 | 34 |
Why?
| Magnetic Resonance Imaging | 4 | 2006 | 294 |
Why?
| Anti-Arrhythmia Agents | 1 | 1992 | 36 |
Why?
| Cholesterol | 1 | 1992 | 86 |
Why?
| Sepsis | 2 | 1981 | 73 |
Why?
| Questionnaires | 5 | 1997 | 360 |
Why?
| Hemostasis | 2 | 1999 | 44 |
Why?
| Fear | 2 | 2007 | 34 |
Why?
| Prospective Studies | 9 | 1999 | 545 |
Why?
| Regression Analysis | 8 | 1985 | 256 |
Why?
| Dopamine | 1 | 1992 | 62 |
Why?
| Light Coagulation | 1 | 2010 | 4 |
Why?
| Vulvodynia | 1 | 2010 | 7 |
Why?
| Carbazoles | 1 | 2010 | 21 |
Why?
| Sample Size | 1 | 2010 | 24 |
Why?
| Treatment Outcome | 11 | 1996 | 661 |
Why?
| Recurrence | 10 | 1988 | 261 |
Why?
| Stochastic Processes | 1 | 2010 | 22 |
Why?
| Intensive Care | 1 | 2010 | 33 |
Why?
| Blindness | 1 | 2010 | 22 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2010 | 18 |
Why?
| Shock, Septic | 1 | 2010 | 40 |
Why?
| Apolipoproteins B | 1 | 1992 | 18 |
Why?
| Diabetic Retinopathy | 1 | 2010 | 14 |
Why?
| Leukemia | 2 | 1982 | 70 |
Why?
| Aged, 80 and over | 8 | 1988 | 599 |
Why?
| Prognosis | 7 | 1982 | 388 |
Why?
| Genetic Predisposition to Disease | 3 | 2005 | 131 |
Why?
| Food Habits | 1 | 2009 | 15 |
Why?
| Statistics, Nonparametric | 1 | 2010 | 141 |
Why?
| Hospital Mortality | 1 | 2010 | 60 |
Why?
| Eating | 1 | 2009 | 37 |
Why?
| Sex Characteristics | 1 | 2010 | 85 |
Why?
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2009 | 6 |
Why?
| Carbidopa | 2 | 2004 | 10 |
Why?
| Weight Loss | 1 | 2009 | 51 |
Why?
| Vulvar Diseases | 1 | 2009 | 19 |
Why?
| Physician-Nurse Relations | 2 | 1997 | 2 |
Why?
| Corpus Striatum | 4 | 2001 | 48 |
Why?
| Insurance Selection Bias | 1 | 2008 | 3 |
Why?
| Interleukin-1beta | 1 | 2009 | 36 |
Why?
| Neurofilament Proteins | 1 | 2008 | 18 |
Why?
| Chorea | 1 | 2008 | 5 |
Why?
| Methods | 1 | 2008 | 133 |
Why?
| Computer Simulation | 1 | 2010 | 134 |
Why?
| Body Mass Index | 1 | 2009 | 122 |
Why?
| Withholding Treatment | 1 | 2008 | 23 |
Why?
| Pleural Diseases | 2 | 1984 | 11 |
Why?
| Likelihood Functions | 2 | 1995 | 43 |
Why?
| Recognition (Psychology) | 1 | 2007 | 12 |
Why?
| Pain Measurement | 1 | 2009 | 98 |
Why?
| Time Factors | 9 | 1981 | 896 |
Why?
| Fatigue | 1 | 2008 | 48 |
Why?
| Drug Combinations | 3 | 1997 | 95 |
Why?
| Insurance, Health | 1 | 2008 | 58 |
Why?
| Incidence | 4 | 1990 | 336 |
Why?
| Cohort Studies | 5 | 1989 | 332 |
Why?
| Emotions | 1 | 2007 | 58 |
Why?
| Head Injuries, Closed | 1 | 2006 | 9 |
Why?
| Behavioral Symptoms | 1 | 2006 | 10 |
Why?
| Statistics as Topic | 2 | 1983 | 133 |
Why?
| Memory Disorders | 1 | 2007 | 29 |
Why?
| Epithelial Cells | 1 | 2009 | 135 |
Why?
| Hypotension, Orthostatic | 1 | 2006 | 10 |
Why?
| Disorders of Excessive Somnolence | 1 | 2006 | 7 |
Why?
| Algorithms | 1 | 2010 | 226 |
Why?
| Confusion | 1 | 2006 | 6 |
Why?
| Predictive Value of Tests | 4 | 2007 | 321 |
Why?
| Decision Making | 2 | 1997 | 130 |
Why?
| Welding | 2 | 1982 | 4 |
Why?
| Population Dynamics | 1 | 1986 | 14 |
Why?
| Population Density | 1 | 1986 | 12 |
Why?
| Adolescent | 11 | 1981 | 891 |
Why?
| Angina, Unstable | 1 | 2005 | 20 |
Why?
| Pain | 1 | 2009 | 191 |
Why?
| Psychomotor Disorders | 1 | 2005 | 18 |
Why?
| Dietary Supplements | 1 | 2005 | 34 |
Why?
| Neoplasms | 2 | 1984 | 239 |
Why?
| Membrane Glycoproteins | 3 | 2001 | 154 |
Why?
| Risk Factors | 7 | 1996 | 555 |
Why?
| Thoracic Injuries | 1 | 1984 | 22 |
Why?
| Abdominal Injuries | 1 | 1984 | 15 |
Why?
| Splenectomy | 2 | 1981 | 29 |
Why?
| Cognition | 1 | 2006 | 97 |
Why?
| Thoracoscopy | 1 | 1984 | 5 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2009 | 210 |
Why?
| Sex Factors | 4 | 1985 | 284 |
Why?
| Lung | 2 | 1985 | 232 |
Why?
| Pathology | 1 | 1984 | 25 |
Why?
| Parkinsonian Disorders | 1 | 2004 | 19 |
Why?
| Coronary Artery Disease | 1 | 2005 | 56 |
Why?
| Dihydroxyphenylalanine | 1 | 2003 | 12 |
Why?
| Technology Assessment, Biomedical | 1 | 2003 | 19 |
Why?
| Neuropeptides | 1 | 2003 | 27 |
Why?
| Hypolipidemic Agents | 1 | 2004 | 17 |
Why?
| Nuclear Proteins | 1 | 2007 | 139 |
Why?
| Pacifiers | 1 | 2003 | 5 |
Why?
| Bottle Feeding | 1 | 2003 | 12 |
Why?
| Logistic Models | 4 | 1999 | 251 |
Why?
| Hyperparathyroidism, Secondary | 1 | 1982 | 6 |
Why?
| Diseases in Twins | 1 | 1982 | 30 |
Why?
| Drowning | 1 | 1982 | 4 |
Why?
| Diagnostic Imaging | 1 | 2003 | 66 |
Why?
| Disabled Persons | 1 | 2002 | 35 |
Why?
| Resuscitation | 1 | 1982 | 31 |
Why?
| Lye | 1 | 1982 | 1 |
Why?
| Burns, Chemical | 1 | 1982 | 3 |
Why?
| Absenteeism | 1 | 1982 | 26 |
Why?
| Neurodegenerative Diseases | 1 | 2002 | 30 |
Why?
| Caustics | 1 | 1982 | 2 |
Why?
| Esophageal Stenosis | 1 | 1982 | 13 |
Why?
| Calcium Sulfate | 1 | 1982 | 7 |
Why?
| Serum Amyloid A Protein | 1 | 2002 | 15 |
Why?
| Skin Transplantation | 1 | 1982 | 39 |
Why?
| Hemochromatosis | 1 | 2002 | 8 |
Why?
| Asbestos | 1 | 1982 | 11 |
Why?
| Quality of Life | 1 | 2006 | 188 |
Why?
| Publications | 1 | 2001 | 5 |
Why?
| Reaction Time | 3 | 2006 | 81 |
Why?
| Research Design | 2 | 1990 | 169 |
Why?
| Bibliometrics | 1 | 2001 | 6 |
Why?
| Dust | 1 | 1982 | 22 |
Why?
| Histocompatibility Antigens Class I | 1 | 2002 | 32 |
Why?
| Stomach | 1 | 1982 | 44 |
Why?
| DNA Mutational Analysis | 3 | 2002 | 110 |
Why?
| Mutation, Missense | 1 | 2002 | 59 |
Why?
| Esophagus | 1 | 1982 | 49 |
Why?
| Dose-Response Relationship, Drug | 4 | 1997 | 431 |
Why?
| Heterozygote Detection | 1 | 2000 | 16 |
Why?
| Kidney Neoplasms | 1 | 1982 | 75 |
Why?
| C-Reactive Protein | 1 | 2002 | 54 |
Why?
| Case-Control Studies | 3 | 2006 | 283 |
Why?
| Clozapine | 1 | 2001 | 17 |
Why?
| Models, Biological | 2 | 1982 | 410 |
Why?
| Kidney Transplantation | 1 | 1982 | 66 |
Why?
| Child | 7 | 1981 | 749 |
Why?
| Quebec | 2 | 1982 | 3 |
Why?
| Breast Feeding | 1 | 2003 | 45 |
Why?
| Cell Survival | 1 | 1982 | 229 |
Why?
| Lymphoma | 1 | 2001 | 96 |
Why?
| Bacterial Infections | 1 | 1981 | 88 |
Why?
| Progressive Patient Care | 1 | 1999 | 4 |
Why?
| Phenethylamines | 1 | 1989 | 17 |
Why?
| Tomography, X-Ray Computed | 1 | 1984 | 321 |
Why?
| Patient Transfer | 1 | 1999 | 25 |
Why?
| Interferon-beta | 2 | 1995 | 26 |
Why?
| Interferon Type I | 2 | 1988 | 22 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 3 | 2001 | 17 |
Why?
| Angiography | 2 | 1988 | 63 |
Why?
| Infant | 5 | 1982 | 464 |
Why?
| Antipsychotic Agents | 1 | 2001 | 49 |
Why?
| Reoperation | 2 | 1988 | 106 |
Why?
| Coronary Disease | 2 | 1988 | 94 |
Why?
| Drug Industry | 1 | 2008 | 18 |
Why?
| Membrane Transport Proteins | 3 | 2001 | 43 |
Why?
| Cryosurgery | 2 | 1995 | 12 |
Why?
| Interferons | 2 | 1995 | 39 |
Why?
| Intensive Care Units | 1 | 1999 | 53 |
Why?
| Evaluation Studies as Topic | 1 | 2008 | 178 |
Why?
| Electrocardiography | 3 | 1988 | 132 |
Why?
| Reproducibility of Results | 3 | 2003 | 391 |
Why?
| Constriction, Pathologic | 1 | 1998 | 65 |
Why?
| Patient Care Team | 1 | 1999 | 119 |
Why?
| Biometry | 1 | 1998 | 32 |
Why?
| Socioeconomic Factors | 1 | 1999 | 144 |
Why?
| Adenocarcinoma | 1 | 1982 | 167 |
Why?
| Membrane Proteins | 1 | 2002 | 233 |
Why?
| Treatment Failure | 1 | 1998 | 88 |
Why?
| Cryotherapy | 1 | 1997 | 12 |
Why?
| Verbal Learning | 2 | 2007 | 21 |
Why?
| Genotype | 3 | 2000 | 175 |
Why?
| Child, Preschool | 4 | 1982 | 554 |
Why?
| Biomedical Research | 1 | 2008 | 87 |
Why?
| Data Interpretation, Statistical | 2 | 2005 | 109 |
Why?
| Critical Care | 1 | 1997 | 34 |
Why?
| Great Britain | 4 | 1981 | 49 |
Why?
| Mental Recall | 2 | 2006 | 36 |
Why?
| Thrombosis | 1 | 1999 | 105 |
Why?
| Hallucinations | 2 | 2005 | 12 |
Why?
| Administration, Oral | 2 | 2002 | 170 |
Why?
| Arrhythmias, Cardiac | 2 | 1992 | 65 |
Why?
| Young Adult | 2 | 2008 | 380 |
Why?
| Putamen | 2 | 2001 | 10 |
Why?
| Caudate Nucleus | 2 | 2001 | 14 |
Why?
| Drug Therapy, Combination | 3 | 1989 | 189 |
Why?
| Biopsy | 1 | 1996 | 207 |
Why?
| Life Expectancy | 1 | 1995 | 20 |
Why?
| Activities of Daily Living | 3 | 1993 | 122 |
Why?
| California | 1 | 1995 | 40 |
Why?
| Twins, Monozygotic | 2 | 1982 | 28 |
Why?
| Disability Evaluation | 2 | 1997 | 61 |
Why?
| Confidence Intervals | 2 | 2002 | 104 |
Why?
| Age Factors | 3 | 1985 | 480 |
Why?
| Interferon-alpha | 2 | 1990 | 43 |
Why?
| Coenzymes | 2 | 2002 | 16 |
Why?
| Placebos | 1 | 1993 | 110 |
Why?
| Lung Neoplasms | 2 | 1988 | 159 |
Why?
| Chromatography, Gas | 1 | 1992 | 21 |
Why?
| Homovanillic Acid | 1 | 1992 | 19 |
Why?
| Psychiatric Status Rating Scales | 2 | 1993 | 99 |
Why?
| Spectrophotometry | 1 | 1992 | 53 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1992 | 121 |
Why?
| Brain | 2 | 2008 | 305 |
Why?
| Administration, Intravaginal | 1 | 2010 | 10 |
Why?
| Patient Care | 1 | 2010 | 30 |
Why?
| Analysis of Variance | 2 | 1999 | 339 |
Why?
| Combined Modality Therapy | 3 | 1995 | 219 |
Why?
| Dietary Proteins | 1 | 2009 | 26 |
Why?
| Chemokine CXCL1 | 1 | 2009 | 10 |
Why?
| Dietary Carbohydrates | 1 | 2009 | 23 |
Why?
| Metalloproteases | 1 | 2009 | 12 |
Why?
| Myocardial Contraction | 1 | 1989 | 52 |
Why?
| Multivariate Analysis | 3 | 1991 | 225 |
Why?
| Energy Intake | 1 | 2009 | 38 |
Why?
| Odds Ratio | 1 | 2010 | 157 |
Why?
| Coitus | 1 | 2009 | 17 |
Why?
| Baclofen | 1 | 1989 | 7 |
Why?
| Chemokine CXCL2 | 1 | 2009 | 29 |
Why?
| Dietary Fats | 1 | 2009 | 33 |
Why?
| Forecasting | 1 | 1990 | 147 |
Why?
| Databases, Factual | 1 | 2009 | 102 |
Why?
| Feasibility Studies | 1 | 2009 | 144 |
Why?
| Drug Synergism | 1 | 2009 | 104 |
Why?
| Trinucleotide Repeat Expansion | 1 | 2009 | 21 |
Why?
| Comorbidity | 1 | 2010 | 190 |
Why?
| Hypotension | 1 | 1988 | 33 |
Why?
| Energy Metabolism | 1 | 2009 | 80 |
Why?
| Pulmonary Valve | 1 | 1988 | 11 |
Why?
| Stroke Volume | 3 | 1988 | 54 |
Why?
| Tetralogy of Fallot | 1 | 1988 | 12 |
Why?
| Tricuspid Valve | 1 | 1988 | 16 |
Why?
| Canada | 1 | 2008 | 60 |
Why?
| Movement | 1 | 2009 | 69 |
Why?
| Subclavian Artery | 1 | 1988 | 22 |
Why?
| Chemical Industry | 1 | 1988 | 3 |
Why?
| Olfaction Disorders | 1 | 2007 | 3 |
Why?
| Acetylene | 1 | 1988 | 7 |
Why?
| Animals | 4 | 1981 | 1031 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2007 | 14 |
Why?
| RNA, Small Interfering | 1 | 2009 | 116 |
Why?
| Early Diagnosis | 1 | 2007 | 23 |
Why?
| Hypertension | 1 | 1991 | 161 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 67 |
Why?
| Pulmonary Artery | 1 | 1988 | 58 |
Why?
| Patient Selection | 1 | 2009 | 155 |
Why?
| Heart Defects, Congenital | 1 | 1988 | 55 |
Why?
| Anger | 1 | 2007 | 14 |
Why?
| Facial Expression | 1 | 2007 | 13 |
Why?
| Pattern Recognition, Visual | 1 | 2007 | 20 |
Why?
| Exercise | 1 | 1988 | 82 |
Why?
| Pregnancy | 2 | 1982 | 455 |
Why?
| Social Perception | 1 | 2007 | 28 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 224 |
Why?
| Unconsciousness | 1 | 2006 | 5 |
Why?
| Cell Membrane | 1 | 2009 | 170 |
Why?
| Twins, Dizygotic | 1 | 2006 | 7 |
Why?
| Palliative Care | 1 | 1988 | 65 |
Why?
| Dopamine Agents | 1 | 2006 | 19 |
Why?
| Attention | 1 | 2007 | 64 |
Why?
| Postoperative Complications | 2 | 1981 | 305 |
Why?
| Motor Skills Disorders | 1 | 2006 | 5 |
Why?
| Photic Stimulation | 1 | 2007 | 58 |
Why?
| Dopamine Agonists | 1 | 2006 | 14 |
Why?
| Prodrugs | 1 | 2006 | 16 |
Why?
| International Cooperation | 1 | 2006 | 42 |
Why?
| Delusions | 1 | 2005 | 5 |
Why?
| Medical Records | 1 | 2006 | 104 |
Why?
| Calcinosis | 1 | 1985 | 54 |
Why?
| Pulmonary Edema | 2 | 1988 | 24 |
Why?
| Sensitivity and Specificity | 1 | 2009 | 427 |
Why?
| Meta-Analysis as Topic | 1 | 2005 | 30 |
Why?
| Basal Ganglia Diseases | 1 | 2005 | 14 |
Why?
| Fires | 1 | 1985 | 6 |
Why?
| Videotape Recording | 1 | 2005 | 45 |
Why?
| Inflammation | 1 | 2009 | 208 |
Why?
| Occupational Medicine | 1 | 1985 | 16 |
Why?
| Wounds, Penetrating | 1 | 1984 | 21 |
Why?
| Observer Variation | 1 | 2005 | 103 |
Why?
| Injections, Subcutaneous | 2 | 1990 | 63 |
Why?
| Area Under Curve | 1 | 2004 | 47 |
Why?
| Empyema | 1 | 1984 | 1 |
Why?
| Iodine Radioisotopes | 1 | 2004 | 64 |
Why?
| DNA | 1 | 2009 | 262 |
Why?
| Blood Coagulation Factors | 1 | 2004 | 31 |
Why?
| Pneumothorax | 1 | 1984 | 16 |
Why?
| Cell Line | 1 | 2009 | 375 |
Why?
| Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 1 |
Why?
| Vesicular Monoamine Transport Proteins | 1 | 2003 | 1 |
Why?
| Pleural Effusion | 1 | 1984 | 24 |
Why?
| Wounds, Nonpenetrating | 1 | 1984 | 32 |
Why?
| Pancreas | 1 | 1984 | 46 |
Why?
| Foreign Bodies | 1 | 1984 | 36 |
Why?
| Radiopharmaceuticals | 1 | 2003 | 37 |
Why?
| Particle Size | 1 | 2004 | 55 |
Why?
| Infant Equipment | 1 | 2003 | 5 |
Why?
| Sucking Behavior | 1 | 2003 | 9 |
Why?
| Feeding Methods | 1 | 2003 | 5 |
Why?
| Lipoproteins | 1 | 2004 | 52 |
Why?
| Sampling Studies | 1 | 2003 | 40 |
Why?
| Siblings | 1 | 2003 | 28 |
Why?
| Parathyroid Glands | 1 | 1982 | 10 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2003 | 13 |
Why?
| Parathyroid Neoplasms | 1 | 1982 | 9 |
Why?
| Basal Ganglia | 1 | 2003 | 23 |
Why?
| Birth Weight | 1 | 2003 | 50 |
Why?
| Adenoma | 1 | 1982 | 46 |
Why?
| Contrast Media | 1 | 1984 | 116 |
Why?
| Barbiturates | 1 | 1982 | 12 |
Why?
| Coma | 1 | 1982 | 12 |
Why?
| Australia | 1 | 2002 | 27 |
Why?
| Hypothermia, Induced | 1 | 1982 | 16 |
Why?
| Cystadenoma | 1 | 1982 | 5 |
Why?
| Gene Frequency | 1 | 2002 | 42 |
Why?
| Ferritins | 1 | 2002 | 36 |
Why?
| Cytoprotection | 1 | 2002 | 32 |
Why?
| Infant, Newborn | 2 | 1988 | 389 |
Why?
| Pyelonephritis | 1 | 1982 | 15 |
Why?
| Glomerulonephritis | 1 | 1982 | 20 |
Why?
| Mathematics | 1 | 1982 | 75 |
Why?
| Gastrectomy | 1 | 1982 | 13 |
Why?
| Liver Cirrhosis | 1 | 2002 | 48 |
Why?
| Meat-Packing Industry | 1 | 1981 | 1 |
Why?
| Data Collection | 1 | 2003 | 137 |
Why?
| Dominance, Cerebral | 1 | 2001 | 34 |
Why?
| Adrenal Cortex Hormones | 1 | 1982 | 76 |
Why?
| Tuftsin | 1 | 1981 | 1 |
Why?
| Esophagoscopy | 1 | 1982 | 22 |
Why?
| Nephrectomy | 1 | 1982 | 36 |
Why?
| Morbidity | 1 | 1981 | 62 |
Why?
| Warts | 1 | 1981 | 13 |
Why?
| Smoking | 2 | 1982 | 153 |
Why?
| Opsonin Proteins | 1 | 1981 | 12 |
Why?
| Continental Population Groups | 1 | 2002 | 85 |
Why?
| Psychomotor Performance | 1 | 1993 | 69 |
Why?
| Immunoglobulins | 1 | 1981 | 54 |
Why?
| RNA, Messenger | 1 | 2009 | 394 |
Why?
| Brief Psychiatric Rating Scale | 1 | 2001 | 10 |
Why?
| Heart Diseases | 1 | 2002 | 92 |
Why?
| Complement System Proteins | 1 | 1981 | 30 |
Why?
| Virus Diseases | 1 | 1981 | 50 |
Why?
| Hand | 1 | 1981 | 37 |
Why?
| Phagocytosis | 1 | 1981 | 51 |
Why?
| Transplantation, Autologous | 1 | 1981 | 78 |
Why?
| Kidney | 1 | 1984 | 223 |
Why?
| Risk Assessment | 1 | 2005 | 324 |
Why?
| Brain Neoplasms | 1 | 1984 | 116 |
Why?
| Child Development | 1 | 2003 | 49 |
Why?
| Blood Coagulation | 1 | 2000 | 57 |
Why?
| Antibody Formation | 1 | 1981 | 89 |
Why?
| Reference Values | 1 | 2001 | 278 |
Why?
| Pneumonia | 1 | 1982 | 85 |
Why?
| United States | 1 | 2008 | 604 |
Why?
| Prevalence | 1 | 2002 | 281 |
Why?
| Lymphocytes | 1 | 1981 | 142 |
Why?
| Cross-Sectional Studies | 1 | 2002 | 253 |
Why?
| Liver | 1 | 1984 | 248 |
Why?
| Emergency Service, Hospital | 1 | 1982 | 94 |
Why?
| APACHE | 1 | 1999 | 18 |
Why?
| Physicians | 1 | 1981 | 104 |
Why?
| Factor VII | 1 | 1999 | 10 |
Why?
| Factor VIIa | 1 | 1999 | 12 |
Why?
| Suicide, Attempted | 1 | 1982 | 42 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 1999 | 16 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 1999 | 26 |
Why?
| von Willebrand Factor | 1 | 1999 | 34 |
Why?
| Alzheimer Disease | 1 | 2002 | 71 |
Why?
| Hemodynamics | 2 | 1988 | 131 |
Why?
| Suicide | 1 | 1984 | 60 |
Why?
| Cooperative Behavior | 1 | 1999 | 70 |
Why?
| Linear Models | 1 | 1999 | 151 |
Why?
| Attitude of Health Personnel | 2 | 1981 | 165 |
Why?
| Health Care Surveys | 1 | 1999 | 91 |
Why?
| Fibrinogen | 1 | 1999 | 45 |
Why?
| Length of Stay | 1 | 1999 | 166 |
Why?
| Anti-Bacterial Agents | 1 | 1982 | 195 |
Why?
| Phenotype | 1 | 2000 | 303 |
Why?
| Mice | 1 | 2009 | 623 |
Why?
| Primary Health Care | 1 | 2002 | 151 |
Why?
| Educational Status | 1 | 1997 | 99 |
Why?
| Insulin | 1 | 1999 | 129 |
Why?
| Vital Capacity | 2 | 1985 | 25 |
Why?
| Forced Expiratory Volume | 2 | 1985 | 29 |
Why?
| Papillomaviridae | 2 | 1981 | 37 |
Why?
| Sexual Partners | 1 | 1995 | 23 |
Why?
| New York | 1 | 1999 | 422 |
Why?
| Antiviral Agents | 1 | 1996 | 91 |
Why?
| England | 2 | 1981 | 20 |
Why?
| Interferon-gamma | 1 | 1995 | 133 |
Why?
| Bisexuality | 1 | 1990 | 9 |
Why?
| Homosexuality | 1 | 1990 | 17 |
Why?
| Ventricular Function, Left | 1 | 1991 | 41 |
Why?
| Pulmonary Circulation | 1 | 1989 | 42 |
Why?
| DNA, Viral | 1 | 1990 | 98 |
Why?
| Angina Pectoris | 1 | 1988 | 31 |
Why?
| Heart Catheterization | 1 | 1988 | 47 |
Why?
| RNA, Viral | 1 | 1990 | 91 |
Why?
| Sutures | 1 | 1988 | 18 |
Why?
| Exercise Test | 1 | 1988 | 51 |
Why?
| Anus Neoplasms | 1 | 1988 | 11 |
Why?
| Coronary Angiography | 1 | 1988 | 49 |
Why?
| Genital Neoplasms, Female | 1 | 1988 | 27 |
Why?
| Genital Neoplasms, Male | 1 | 1988 | 16 |
Why?
| Injections | 1 | 1988 | 53 |
Why?
| Anastomosis, Surgical | 1 | 1988 | 45 |
Why?
| Suture Techniques | 1 | 1988 | 48 |
Why?
| Stomach Neoplasms | 1 | 1988 | 28 |
Why?
| Random Allocation | 1 | 1988 | 160 |
Why?
| Survival Rate | 1 | 1990 | 250 |
Why?
| Recombinant Proteins | 1 | 1990 | 290 |
Why?
| Pancreatic Neoplasms | 1 | 1988 | 46 |
Why?
| Greece | 1 | 1985 | 5 |
Why?
| Ships | 1 | 1985 | 1 |
Why?
| Air Pollutants, Occupational | 1 | 1985 | 10 |
Why?
| Neoplasm Recurrence, Local | 1 | 1988 | 118 |
Why?
| London | 1 | 1985 | 7 |
Why?
| Smoke | 1 | 1985 | 20 |
Why?
| Polyomaviridae | 1 | 1981 | 1 |
Why?
| Medical Staff, Hospital | 1 | 1981 | 31 |
Why?
| Family Practice | 1 | 1981 | 84 |
Why?
| Aging | 1 | 1985 | 275 |
Why?
|
|
Oakes's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
